AlphaGen Therapeutics
PrivateLast Round
Series A
Aug 7, 2025
Company Overview
AlphaGen Therapeutics is a biopharmaceutical company that focuses on the discovery, development, manufacturing, and commercialization of innovative targeted radioligand therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlphaGen Therapeutics Comparables
Compare AlphaGen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| C-Ray Therapeutics | 88% | |
| AdvanCell | 85% | |
| ARTBIO | 85% |
AlphaGen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 7, 2025 | ||||
| Seed | Oct 18, 2023 |
Key People
Founding team and executive leadership
AlphaGen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eight Roads Ventures | Seed |
| Eight Roads Ventures China | Seed |
| F-Prime Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Two next-generation alpha therapies are in preclinical studies.
- Apr 21, 2026
Presenting preclinical studies at AACR 2026.
AlphaGen Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AlphaGen Therapeutics's valuation, stock price, and market status.
Is AlphaGen Therapeutics a public or private company?
AlphaGen Therapeutics is a private company.
What is the current stock price of AlphaGen Therapeutics?
AlphaGen Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is AlphaGen Therapeutics worth (valuation)?
Valuation information for AlphaGen Therapeutics is not publicly available.
Can I buy AlphaGen Therapeutics stock?
AlphaGen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AlphaGen Therapeutics's last funding round?
AlphaGen Therapeutics's most recent funding round was Series A on August 7, 2025.
Who are the main investors in AlphaGen Therapeutics?
Key investors in AlphaGen Therapeutics include Eight Roads Ventures China.
Will AlphaGen Therapeutics IPO soon?
No public IPO plans have been announced for AlphaGen Therapeutics.
How can I track AlphaGen Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AlphaGen Therapeutics's secondary market activity and sign up for updates.